Humana (HUM) Other Accumulated Expenses (2009 - 2026)

Humana's Other Accumulated Expenses history runs 18 years deep, the most recent figure standing at $12.7 billion for Q1 2026.

• In Q1 2026, Other Accumulated Expenses rose 10.83% year-over-year to $12.7 billion; the TTM figure through Mar 2026 stood at $12.7 billion (up 10.83% YoY), while the FY2025 annual figure was $10.0 billion, down 4.53% from the prior year.
• Other Accumulated Expenses was $12.7 billion for Q1 2026 at Humana, up from $10.0 billion in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $12.7 billion in Q1 2026 to a low of $9.2 billion in Q3 2022.
• Historically, Other Accumulated Expenses has averaged $10.5 billion across 5 years, with a median of $10.2 billion in 2023.
• The sharpest annual moves came in 2024 and 2025: Other Accumulated Expenses gained 17.08% in 2024, then slipped 9.32% in 2025.
• A 5-year view of Other Accumulated Expenses shows it stood at $9.3 billion in 2022, then climbed by 10.55% to $10.2 billion in 2023, then grew by 1.94% to $10.4 billion in 2024, then slipped by 4.53% to $10.0 billion in 2025, then advanced by 27.33% to $12.7 billion in 2026.
• The last three Other Accumulated Expenses figures came in at $12.7 billion (Q1 2026), $10.0 billion (Q4 2025), and $10.1 billion (Q3 2025), per Business Quant data.